Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Reviews
Nature Immunology
Nature Cell Biology
Nature Genetics
news@nature.com
Nature Conferences
Dissect Medicine
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Technical Report
Nature Medicine  9, 1539 - 1544 (2003)
Published online: 23 November 2003; | doi:10.1038/nm964

Local gene knockdown in the brain using viral-mediated RNA interference

Jonathan D Hommel, Robert M Sears, Dan Georgescu, Diana L Simmons & Ralph J DiLeone

Department of Psychiatry, The University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd., Dallas, Texas 75390−9070, USA.

Correspondence should be addressed to Ralph J DiLeone ralph.dileone@utsouthwestern.edu
Conditional mutant techniques that allow spatial and temporal control over gene expression can be used to create mice with restricted genetic modifications. These mice serve as powerful disease models in which gene function in adult tissues can be specifically dissected. Current strategies for conditional genetic manipulation are inefficient, however, and often lack sufficient spatial control. Here we use viral-mediated RNA interference (RNAi) to generate a specific knockdown of Th, the gene encoding the dopamine synthesis enzyme tyrosine hydroxylase, within midbrain neurons of adult mice. This localized gene knockdown resulted in behavioral changes, including a motor performance deficit and reduced response to a psychostimulant. These results underscore the potential of using viral-mediated RNAi for the rapid production and testing of new genetic disease models. Similar strategies may be used in other model species, and may ultimately find applications in human gene therapy.

MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated

REFERENCE
Motor System Organization
Nature Encyclopaedia of Life Sciences
 See all 5 matches for Reference

REVIEWS
The role of alpha-synuclein in Parkinson's disease: insights from animal models
Nature Reviews Neuroscience Review (01 Sep 2003)
 See all 13 matches for Reviews

NEWS AND VIEWS
NOS knockouts and neuroprotection
Nature Medicine News and Views (01 Dec 1999)
Neural stem cells, scaffolds, and chaperones
Nature Biotechnology Research News (01 Nov 2002)
 See all 3 matches for News And Views

RESEARCH
Loss of bidirectional striatal synaptic plasticity in L-DOPA–induced dyskinesia
Nature Neuroscience Article (01 May 2003)
 See all 18 matches for Research

 Top
Abstract
Previous
Table of contents
Full textFull text
Download PDFDownload PDF
Send to a friendSend to a friend

Open Innovation Challenges

naturejobs

Figures & Tables
Supplementary info
Export citation
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Medicine
ISSN: 1078-8956
EISSN: 1546-170X
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | For authors | Online submission | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | Reprints and permissions | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2003 Nature Publishing Group | Privacy policy